EUVIMEDEUVIMED entdecken
Editorial

Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside

Liping Zhou iD, Annette Bak iD, Kenji Hyodo, Bertil Abrahamsson iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.3c00831 ↗

Kurz gefasst

Editorial in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Liping Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceutical R&D, AstraZeneca Boston, Waltham, Massachusetts 02451, United States. Hauptthemen laut MEDLINE: Biopharmaceutics, Pharmacy. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTIntroducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to BedsideLiping ZhouLiping ZhouAdvanced Drug Delivery, Pharmaceutical Science, BioPharmaceutical R&D, AstraZeneca Boston, Waltham, Massachusetts 02451, United StatesMore by Liping Zhouhttps://orcid.org/0000-0003-2353-6134, Annette BakAnnette BakAdvanced Drug Delivery, Pharmaceutical Science, BioPharmaceutical R&D, AstraZeneca Boston, Waltham, Massachusetts 02451, United StatesMore by Annette Bakhttps://orcid.org/0009-0000-7607-6050, Kenji HyodoKenji HyodoAdvanced Drug Delivery, Emerging Modality Generation Department, Discovery Evidence Generation Function, Deep Human Biology Learning, Eisai Co., Ltd., Tokyo 112-8088, JapanMore by Kenji Hyodo, and Bertil Abrahamsson*Bertil AbrahamssonOral Product Development, Pharmaceutical Technology Development, Operations, AstraZeneca Gothenburg, 431 50 Mölndal, SwedenMore by Bertil Abrahamssonhttps://orcid.org/0000-0003-4490-7491Cite this: Mol. Pharmaceutics 2023, 20, 10, 4797–4799Publication Date (Web):October 2, 2023Publication History Received12 September 2023Published online2 October 2023Published inissue 2 October 2023https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.3c00831https://doi.org/10.1021/acs.molpharmaceut.3c00831editorialACS PublicationsCopyright © Published 2023 by American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1164Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (1 MB) Get e-AlertscloseSUBJECTS:Drug delivery,Pharmaceuticals,Pharmaceutics,Small molecules,Vaccination Get e-Alerts

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiopharmaceuticsPharmacyDrug Delivery SystemsChemistry, Pharmaceutical

Autor:innen und Institutionen

  • Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceutical R&D, AstraZeneca Boston, Waltham, Massachusetts 02451, United States.
  • Advanced Drug Delivery, Emerging Modality Generation Department, Discovery Evidence Generation Function, Deep Human Biology Learning, Eisai Co., Ltd., Tokyo 112-8088, Japan.
  • Oral Product Development, Pharmaceutical Technology Development, Operations, AstraZeneca Gothenburg, 431 50 Mölndal, Sweden.

ORCID-Profile: Liping Zhou, Annette Bak, Bertil Abrahamsson

Zitieren

APA

Zhou, L., Bak, A., Hyodo, K., & Abrahamsson, B. (2023). Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00831

Vancouver

Zhou L, Bak A, Hyodo K, Abrahamsson B. Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00831

BibTeX
@article{Zhou2023,
  author = {Zhou, Liping and Bak, Annette and Hyodo, Kenji and Abrahamsson, Bertil},
  title = {Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.3c00831}
}
Kostenlos starten →